Daniel Stauder
Stock Analyst at JMP Securities
(3.27)
# 1,000
Out of 4,876 analysts
17
Total ratings
50%
Success rate
5.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Reiterates: Market Outperform | $33 | $30.62 | +7.77% | 4 | May 6, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $32.88 | +82.48% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $3.40 | +105.88% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $82.40 | +33.50% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $803.95 | -9.82% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $12.17 | - | 1 | May 7, 2024 |
Artivion
May 6, 2025
Reiterates: Market Outperform
Price Target: $33
Current: $30.62
Upside: +7.77%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $32.88
Upside: +82.48%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $3.40
Upside: +105.88%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $82.40
Upside: +33.50%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $803.95
Upside: -9.82%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $12.17
Upside: -